SB 535 formally paves the way for health care clinics to become 'experimental treatment centers' that can provide drugs still in development to willing patients.
Roughly 11% of children and 6% of adults in the U.S are currently diagnosed with ADHDβrates that are significantly higher than those reported in most other countries.